UnitedHealth Group (UNH) Given “Buy” Rating at Cantor Fitzgerald
UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating reissued by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Tuesday. They presently have a $235.00 price objective on the healthcare conglomerate’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 2.78% from the company’s previous close.
The analysts wrote, “This morning, UNH reported better-than-expected 4Q17 results and increased its 2018 guidance due to lower tax rate assumptions.””
A number of other brokerages also recently issued reports on UNH. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Piper Jaffray Companies boosted their price target on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a report on Tuesday, October 17th. Jefferies Group restated a “buy” rating and set a $248.00 price target on shares of UnitedHealth Group in a report on Friday, December 1st. Finally, Credit Suisse Group started coverage on UnitedHealth Group in a report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $229.54.
Shares of UnitedHealth Group (UNH) opened at $228.64 on Tuesday. UnitedHealth Group has a 52 week low of $156.09 and a 52 week high of $231.77. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $221,060.00, a PE ratio of 25.98, a PEG ratio of 1.54 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter in the previous year, the business earned $2.17 EPS. UnitedHealth Group’s revenue was up 8.7% compared to the same quarter last year. analysts expect that UnitedHealth Group will post 9.99 earnings per share for the current year.
In other news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,630 shares of company stock worth $7,669,416. Insiders own 0.89% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of the company. Regal Wealth Group Inc. lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after acquiring an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after acquiring an additional 4 shares in the last quarter. RB Capital Management LLC lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after acquiring an additional 7 shares in the last quarter. RNC Capital Management LLC lifted its position in UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after acquiring an additional 13 shares in the last quarter. Finally, Highland Private Wealth Management lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after acquiring an additional 13 shares in the last quarter. 86.09% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This story was originally posted by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/unitedhealth-group-unh-given-buy-rating-at-cantor-fitzgerald/1809094.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.